Tonix Pharmaceuticals Holding Corp. — Form 8-K
Filed July 21, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Form 8-K filed July 21, 2026 reports Item 5.02 event regarding departure of directors or officers and compensatory arrangements. The specific names, titles, amounts, dates, and terms are not disclosed in the filing metadata provided; full details require access to the complete 8-K document text.
Why this rating
Standard 8-K Item 5.02 disclosure; officer transitions common. Insufficient data to assess materiality—no amounts, names, or roles stated here.
Extracted items
See more from July 21, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.